No attachments available.
On September 11, 2017, Medical Readiness awarded a Pharmaceutical contract to Alvogen, Inc. for fourteen (14) product lines
Contact and place of performance
Sunday O. Oladele
Not specified
On September 11, 2017, DLA Troop Support awarded a new contract SPE2D0-17-D-0008 to Alvogen Inc under Open Season Solicitation SPE2D0-15-R-0002. This is an Indefinite Delivery-Indefinite Quantity (IDIQ) fixed price type contract with Economic Price Adjustment (EPA) clauses for various Pharmaceutical products in support of the Corporate Exigency Contracts (CEC) program. The contract is for ten years (one-year base, wi...
View moreOn September 11, 2017, DLA Troop Support awarded contract SPE2D0-17-D-0008 to Alvogen, Inc. under open season solicitation SPE2D015R0002. This award establishes a ten-year Indefinite Delivery-Indefinite Quantity (IDIQ) fixed-price contract with Economic Price Adjustment clauses, consisting of a one-year base period and nine one-year options. The contract covers fourteen pharmaceutical product lines in support of the Corporate Exigency Contracts program, which facilitates partnerships between the Department of Defense and industry to ensure the industrial base can meet increased demand for critical items during mobilization, war, contingency, and military operations.
This procurement is classified under NAICS 325412 for Pharmaceutical Preparation Manufacturing and PSC code 65. The contract provides the Department of Defense with guaranteed access to various pharmaceutical items designated as critical for military services. Sunday O. Oladele served as the primary point of contact for this award notice.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.